Familial hypercholesterolaemia (FH) is a genetic condition characterised by elevated levels of low-density lipoprotein cholesterol (LDL-C) and an increased risk of cardiovascular disease (CVD). Following dietary and physical activity guidelines could help minimise this risk but adherence is low. Interventions to target these behaviours are therefore required. A comprehensive understanding of the target behaviours and behaviour change theory should drive the process of intervention development to increase intervention effectiveness and scalability. This paper describes the application of a theoretical framework to the findings of a qualitative evidence synthesis (QES) to inform the content and delivery of an intervention to improve adherence...
Abstract Background More insight in the association between reach, dose and fidelity of intervention...
Lifestyle modification is a pivotal intervention for Familial Hypercholesterolaemia (FH). This study...
This evidence synthesis is funded by the National Institute for Health Research NIHR Bristol Biomedi...
This study is funded by the National Institute for Health Research NIHR Bristol Biomedical Research ...
Background Untreated heterozygous familial hypercholesterolaemia (FH) causes high low-density lipop...
Objective Familial hypercholesterolaemia (FH) elevates low-density lipoprotein cholesterol (LDL-C) a...
Objective Familial hypercholesterolaemia (FH) elevates low-density lipoprotein cholesterol (LDL-C) a...
Objective Familial hypercholesterolaemia (FH) elevates low-density lipoprotein cholesterol (LDL-C) a...
Objective Familial hypercholesterolaemia (FH) elevates low-density lipoprotein cholesterol (LDL-C) a...
Objective Familial hypercholesterolaemia (FH) elevates low-density lipoprotein cholesterol (LDL-C) a...
To evaluate the efficacy of an individualised tailored lifestyle intervention on physical activity, ...
To evaluate the efficacy of an individualised tailored lifestyle intervention on physical activity, ...
Background. Because of a high cardiovascular disease (CVD) risk in people with Familial Hypercholest...
Abstract Background Because of a high cardiovascular disease (CVD) risk in people with Familial Hype...
Background: More insight in the association between reach, dose and fidelity of intervention compone...
Abstract Background More insight in the association between reach, dose and fidelity of intervention...
Lifestyle modification is a pivotal intervention for Familial Hypercholesterolaemia (FH). This study...
This evidence synthesis is funded by the National Institute for Health Research NIHR Bristol Biomedi...
This study is funded by the National Institute for Health Research NIHR Bristol Biomedical Research ...
Background Untreated heterozygous familial hypercholesterolaemia (FH) causes high low-density lipop...
Objective Familial hypercholesterolaemia (FH) elevates low-density lipoprotein cholesterol (LDL-C) a...
Objective Familial hypercholesterolaemia (FH) elevates low-density lipoprotein cholesterol (LDL-C) a...
Objective Familial hypercholesterolaemia (FH) elevates low-density lipoprotein cholesterol (LDL-C) a...
Objective Familial hypercholesterolaemia (FH) elevates low-density lipoprotein cholesterol (LDL-C) a...
Objective Familial hypercholesterolaemia (FH) elevates low-density lipoprotein cholesterol (LDL-C) a...
To evaluate the efficacy of an individualised tailored lifestyle intervention on physical activity, ...
To evaluate the efficacy of an individualised tailored lifestyle intervention on physical activity, ...
Background. Because of a high cardiovascular disease (CVD) risk in people with Familial Hypercholest...
Abstract Background Because of a high cardiovascular disease (CVD) risk in people with Familial Hype...
Background: More insight in the association between reach, dose and fidelity of intervention compone...
Abstract Background More insight in the association between reach, dose and fidelity of intervention...
Lifestyle modification is a pivotal intervention for Familial Hypercholesterolaemia (FH). This study...
This evidence synthesis is funded by the National Institute for Health Research NIHR Bristol Biomedi...